Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An **RNA aptamer** is a synthetically generated, short, single-stranded RNA molecule that can fold into a specific three-dimensional conformation, enabling it to bind targets—such as proteins, small molecules, or even cells—with high specificity and affinity[1][2][3][4][5][7]. RNA aptamers are not therapeutic targets themselves but rather function as highly selective binding agents, commonly viewed as nucleic acid "antibody mimics", engineered using the SELEX (*Systematic Evolution of Ligands by EXponential enrichment*) method[1][3][4][5][7]. Their applications include diagnostics, therapeutics, controlled drug delivery, tissue engineering, and biomarker discovery, but an RNA aptamer is not a protein, receptor, or endogenous target—it is a ligand or binding probe[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA aptamer.